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Introduction
Liver dysfunction is seen in less than 3% of women at
delivery. It is usually directly related to pregnancy and
resolves spontaneously during puerperium [1]. How-
ever, more serious conditions can develop, one of the
most dangerous of which is acute fatty liver of pregnancy
(AFLP), a rare but often lethal disease of the third tri-
mester. The reported incidence ranges from 1 in 6,659
to 1 in 13,000 births [2,3]. AFLP is characterized by
profound liver failure and may be accompanied by
renal failure, disseminated intravascular coagulation,
hypoglycemia, and encephalopathy [4]. The maternal
mortality, once reported to be above 70%, is now esti-
mated to be about 18%; reported neonatal mortalities
have ranged from 7% to 58% [2,5–7]. Early recognition
and prompt delivery result in favorable maternal and
fetal outcomes.
The manifestations of AFLP may be confused with
those of severe preeclampsia, HELLP syndrome (hemo-
lysis, elevated liver enzymes, and low platelet count
syndrome), thrombotic microangiopathies, systemic
lupus erythematosus, viral hepatitis, biliary tract dis-
ease, and cholestasis of pregnancy. Given the wide dif-
ferential diagnosis and the need for prompt delivery to
avert death, it is important to diagnose AFLP quickly
and accurately. As a result of its relative rarity, how-
ever, few large case series have been reported in the lit-
erature. It is hoped that as more information on this
disease becomes available, pooling of data will allow
more robust recommendations to be made. In this
study, we therefore reviewed our 22-year experience 
of AFLP.
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SUMMARY
Objective: To evaluate the demographics, clinical presentations, laboratory findings, and maternal and fetal
outcomes in patients with acute fatty liver of pregnancy.
Materials and Methods: A retrospective review was conducted of the records of pregnant patients with a diag-
nosis of acute fatty liver in a tertiary medical center over a 22-year period.
Results: Eighteen patients with acute fatty liver of pregnancy were recruited, all of whom developed the disease
in the third trimester. Eleven women (61%) were primigravid and four (22%) had twin pregnancies; six (33%)
were diagnosed antepartum, and the other 12 (67%) were diagnosed postpartum. There were two maternal
deaths (11%) and four fetal deaths (18%). The most common complications apart from severe liver dysfunction
were acute renal failure (83%), hypoglycemia (61%), and disseminated intravascular coagulation (61%).
Conclusion: Women who become acutely ill during the third trimester of pregnancy should undergo tests for
acute fatty liver of pregnancy, including laboratory tests for assessing liver function and coagulation profile.
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Materials and Methods
The study included patients with AFLP who were man-
aged at Mackay Memorial Hospital, a tertiary care cen-
ter with 5,000 deliveries per year in Taiwan, from January
1984 to December 2006. AFLP was diagnosed in the
presence of acute hepatic failure in the third trimester
of pregnancy and comprised clinical findings, includ-
ing abdominal pain, nausea or vomiting, and labora-
tory evidence of hepatic failure, including elevated
aminotransferase and bilirubin levels, hypoglycemia,
hyperammonemia, and signs of coagulopathy [2,8,9].
Hypertension and proteinuria were usually absent.
Other causes of liver disorder in pregnancy, such as viral
hepatitis, biliary tract disease, HELLP syndrome and
cholestasis of pregnancy, were excluded. AFLP was more
likely than HELLP syndrome to manifest with marked
hypoglycemia, hyperammonemia, and an increased clot-
ting time. Although HELLP syndrome or preeclampsia
may coexist with AFLP, the findings of reduced hepatic
metabolic activity clearly distinguish these different
processes [2,8,9].
Data extracted from the medical records included
demographic characteristics (maternal age, gestational
age, and associated medical conditions), symptoms and
signs, laboratory findings, clinical course, and maternal
and fetal outcomes. Approval for this study was ob-
tained from the institutional review board at Mackay
Memorial Hospital.
Results
There were 136,214 deliveries over the study period of
22 years. Among these, 18 patients were identified with
AFLP. The incidence of AFLP was thus 1 in 7,568 births.
Eleven of the 18 women were primigravid, and four had
twin pregnancies. AFLP was diagnosed in six women
antepartum, in 10 on the day after delivery, and in two
on the third day after delivery. The acute illness occurred
in the third trimester (mean, 35.6 gestational weeks;
range, 30–39 gestational weeks) in all cases. Cesarean
deliveries were performed in 13 cases: seven for fetal
distress, three for malpresentation, one for prolonged
labor, one for placental abruption, and one for unfavor-
able cervix. Progressive jaundice was the most common
symptom (94%), followed by malaise (78%), dark urine
(67%), nausea and vomiting (50%), fever (50%), and
abdominal pain (50%). Abdominal ultrasound was per-
formed in 17 cases, which demonstrated diffusely in-
creased hepatic echogenicity and fat infiltration in 14
cases and ascites in all 17. There were four stillbirths,
and the mean Apgar scores of the live newborns were
low (Table 1). Delivery was preterm for eight women,
three of whom had twin pregnancies. Seven babies had
meconium staining. All the live-born infants survived
and were doing well at follow-up.
The most common maternal morbidities were acute
renal failure, hypoglycemia, and disseminated intravas-
cular coagulation (Table 2). Three women required intu-
bation, two of whom died. One of these had renal
failure, liver dysfunction and disseminated intravascular
coagulation causing massive postpartum hemorrhage
following a cesarean section. She remained in the inten-
sive care unit for 45 days and eventually died of sepsis
and multiple organ failure. The other fatality had been
transferred from another hospital with acute pancre-
atitis leading to multiple organ failure, and died on the
second day. Among the patients who had a complica-
tion of acute renal failure, only one was subjected to
transient hemodialysis during her hospital stay.
Table 1. Clinical features of patients (n = 18) and babies 
(n = 22)*
Maternal age, mean ± SD (yr) 30 ± 5
BMI before delivery, mean ± SD (kg/m2) 24.3 ± 1.2
Gestational age at diagnosis, 35.6 ± 2.8
mean ± SD (wk)
Maternal death, n (%) 2 (11)
Delivery, n (%)
Cesarean section 13 (72)
Vaginal 5 (28)
Fetal weight, mean ± SD (g) 2,385 ± 739
Fetal death, n (%) 4 (18)
Sex of baby, n (%)
Male 13 (59)
Female 9 (41)
Mean Apgar score
1 min 4.9
5 min 6.2
*Four patients had twin pregnancies. SD = standard deviation; BMI = body
mass index.
Table 2. Maternal complications associated with acute
fatty liver of pregnancy of 18 patients
Complication n (%)
Acute renal failure 15 (83)
Hypoglycemia 11 (61)
Disseminated intravascular coagulation 11 (61)
Postpartum hemorrhage 6 (33)
Wound hematoma/dehiscence 5 (28)
Pulmonary edema 3 (17)
Gastrointestinal tract bleeding 2 (11)
Encephalopathy 2 (11)
Acute pancreatitis 2 (11)
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Table 3 summarizes the important laboratory find-
ings obtained at admission, and the nadir or peak values
measured during hospitalization. Other abnormal
findings included prolonged prothrombin time (mean,
25.4 seconds; range, 13.8–60.0 seconds) and partial
thromboplastin time (mean, 83.2 seconds; range,
50.4–120.0 seconds), and reduced fibrinogen (mean,
145 mg/dL; range, 52–295 mg/dL). The mean choles-
terol level was strikingly low. Patients also had persistent
leukocytosis and hyperuricemia. Renal dysfunction oc-
curred in 15 women, presenting after the appearance
of liver failure and resolving before the recovery of liver
function in all cases. Abnormal laboratory findings grad-
ually improved after delivery in all 16 surviving mothers.
The average hospital stay was 19.4 days (range, 2–45
days), including 7.6 days (range, 2–20 days) in the inten-
sive care unit. Five of the women who survived were
known to have a subsequent pregnancy, but none had
a recurrence of AFLP.
Discussion
Recent data indicate a decrease in maternal and neona-
tal mortalities associated with AFLP due to increased
awareness and earlier recognition of the disease [7],
based on its clinical and laboratory findings. Although
there may have been significant changes in the care facil-
ities over the 22-year recruitment period, the maternal
and neonatal outcomes in the current series were simi-
lar to those in previous reports [4,7,10–14]. Laboratory
evidence of acute hepatic failure combined with some
degree of renal impairment may help to distinguish AFLP
from other causes of peripartum jaundice. Disseminated
intravascular coagulation in this syndrome appears to
result from both diminished hepatic synthesis of coagu-
lation factors and increased procoagulant consumption
[10,11]. The low cholesterol levels in our patients were
particularly notable, a finding that helps to differentiate
AFLP from HELLP syndrome [4]. Hypocholesterolemia,
hypofibrinogenemia, and coagulopathy are reflections
of severe liver dysfunction [15], as are marked hypo-
glycemia, elevated serum bilirubin, and abnormal liver
enzymes. The incidence of acute renal failure in AFLP is
over 50% [15], but it is frequently of only moderate
severity and does not usually require dialysis.
Diagnostic imaging modalities such as computerized
tomography or sonography are not considered to be
very helpful in the diagnosis of AFLP [2]. Liver biopsy is the
standard method for confirming the diagnosis [10,12,
16], but it is rarely indicated and may indeed be con-
traindicated because of coagulopathy. A careful history
taking and physical examination, together with confir-
matory laboratory results, are often sufficient to make
the diagnosis [2,9].
We observed two patients with AFLP whose condi-
tions were complicated by acute pancreatitis. Acute
pancreatitis has previously been reported as a compli-
cation of AFLP, but it proved to be lethal in one of our
patients. Moldenhauer et al [17] considered it to be
indicative of a poor prognosis. Establishing a diagnosis of
acute pancreatitis may be difficult, but it has been asso-
ciated with a high maternal death rate and fetal loss rate
[18]. Previous authors have thus recommended screen-
ing patients with AFLP for pancreatitis.
AFLP has never reportedly resolved before delivery.
Expeditious delivery is, therefore, fundamental to its
treatment, although controversy exists over whether
delivery should be by cesarean section or induction of
labor [7]. Induction and vaginal delivery within 24 hours
have produced favorable results [10]. We suggest ce-
sarean section based on other obstetric indications, as
proposed by Sibai [10], and not on the presence of AFLP
alone. Perioperative care of patients with severe hepatic
Table 3. Laboratory findings in mothers with acute fatty liver of pregnancy (n = 18)
Laboratory test On admission, mean (range) Peak/nadir, mean (range)
Glucose (mg/dL) 65 (5–95) 57 (5–95)
Aspartate aminotransferase (IU/L) 208 (19–2, 208) 513 (87–3, 088)
Alanine aminotransferase (IU/L) 156 (22–893) 235 (73–893)
Bilirubin (mg/dL) 8.5 (1.7–20.7) 12.7 (1.7–33.6)
Cholesterol (mg/dL) 103 (51–242) 83 (47–108)
Blood urea nitrogen (mg/dL) 29 (11–55) 38 (15–95)
Creatinine (mg/dL) 2.4 (0.6–4.4) 3.1 (0.6–5.2)
Ammonia (μmol/L) 75 (20–183) 88 (20–207)
Prothrombin time (s) 24.3 (13.8–60) 25.4 (13.8–60)
Partial thromboplastin time (s) 68.9 (50.4–96) 83.2 (50.4–120)
Fibrinogen (mg/dL) 158 (60–295) 145 (52–295)
Platelets (× 103/mm3) 121 (13–219) 68 (13–195)
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dysfunction requires meticulous attention to hemo-
stasis because of the presence of coagulopathy. Cryo-
precipitate or fresh frozen plasma should be used to
correct the prothrombin time [19]. Resolution of the
disease is usually spontaneous following prompt deliv-
ery, although the need for liver transplantation has been
reported in a few cases. However, that remains a poten-
tially dangerous procedure and one that is not widely
available [14]. As with any relatively rare disease, it is not
feasible to define clinical guidelines based on controlled
studies. Therefore, it seems prudent to urge early diag-
nosis and prompt delivery in cases of AFLP [12,20].
Although our data are very limited, at least five women
in this series went on to have subsequent uncomplicated
pregnancies. Too little is known about the risk of recur-
rence to make firm recommendations, but the results of
this study suggest that recurrences are unlikely. Further
data on the recurrence risk would be of great help when
counseling women who have survived AFLP.
Patients should also be followed up in the light of
the association between various defects in fatty acid
oxidation in the offspring and liver disease in the mother
[8,21]. Yang et al [21] identified a particular enzyme
defect in five of 27 families in which the women had a
history of AFLP. They recommended screening newborns
whose mothers have had AFLP for this mutation, to
assist with genetic counseling and nutritional therapy for
the baby [21]. Although likely to be rare, such inborn
errors of metabolism should be considered, given the
rarity of AFLP itself.
This retrospective study adds to the information cur-
rently available for AFLP. The key to its early diagnosis
is a high index of suspicion. Liver and coagulation func-
tions should be carefully evaluated in women in the third
trimester of pregnancy who become acutely ill, partic-
ularly with otherwise unexplained nausea and vomiting
[22]. Prompt delivery of the pregnancy is indicated if
the findings are consistent with AFLP.
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